Teladoc Health, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026New board members bring fresh perspectives and expertise to guide company decisions affecting shareholder value.
Quarterly reports show how well the company is performing financially and help investors track progress over time.
Earnings announcements reveal if the company is making money and growing, which affects stock value.
Director elections decide who leads the company; shareholder votes show investor confidence in management.
Quarterly reports show how well the company is performing financially and help investors track progress over time.
Earnings announcements reveal if the company is making money and growing, which affects stock value.
New board members bring fresh perspectives and expertise to guide company decisions affecting shareholder value.
Stocky reads Teladoc Health, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Teladoc Health, Inc.'s most recent tracked filing was a 8-K on 3 Aug 2026: Appoints Mark Anquillare as director, expands board to ten.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.